4109.T

Stella Chemifa Corporation [4109.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

4109.T Stock Summary

Earnings are expected to fall -100% next year

Unstable dividend track record

Profit margins (0.01%) are lower than the previous year (0.06%)

4109.T has less than 1 year of cash runway

Top 10 Correlated ETFs

4109.T

Top 10 Correlated Stocks

4109.T

In the News

4109.T Financial details

Company Rating

Strong Buy

Market Cap

44.92B

Income

2.33B

Revenue

30.42B

Book val./share

3705.17

Cash/share

1390.92

Dividend

Dividend %

2.74%

Employees

727

Optionable

Shortable

Yes

Earnings

10 May 2024

P/E

112.16

Forward P/E

PEG

-20.7

P/S

1.31

P/B

0.9

P/C

2.67

P/FCF

Quick Ratio

2.78

Current Ratio

3.59

Debt / Equity

0.12

LT Debt / Equity

0.05

EPS (TTM)

193.76

EPS next Y

EPS next Q

EPS this Y

-56.03%

EPS next Y

EPS next 5Y

EPS last 5Y

0.43%

Revenue last 5Y

-1.62%

Revenue Q/Q

22.43%

EPS Q/Q

52.61%

SMA20

-5.25%

SMA50

12.8%

SMA100

16.52%

Inst Own

Inst Trans

ROA

ROE

ROC

0.05%

Gross Margin

21%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

2605.0-3985.0

52W High

-6.9%

52W Low

+42.42%

RSI

Rel Volume

0.34

Avg Volume

33K

Volume

11.3K

Perf Week

1.5%

Perf Month

-2.88%

Perf Quarter

16.12%

Perf Half Y

16.48%

Beta

0.621

Volatility

37.12%, 111.35%

Prev Close

0.54%

Price

3710

Change

0.27%

4109.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.97K	2.61K	2.56K	2.94K	2.89K
Net income per share	181.99	149	230.69	422.93	185.97
Operating cash flow per share	568.81	389.99	573.17	426	459.54
Free cash flow per share	303.57	30.05	383.72	211.54	85.32
Cash per share	1.03K	1.02K	1.18K	1.22K	1.19K
Book value per share	2.54K	2.64K	2.83K	3.33K	3.5K
Tangible book value per share	2.58K	2.64K	2.83K	3.34K	3.5K
Share holders equity per share	2.54K	2.64K	2.83K	3.33K	3.5K
Interest debt per share	962.67	909.63	682.39	429.87	322.51
Market cap	40.03B	31.31B	40.92B	32.93B	32.38B
Enterprise value	38.38B	29.43B	34.07B	22.45B	21.2B
P/E ratio	17.03	16.28	13.83	6.14	14.2
Price to sales ratio	1.04	0.93	1.24	0.88	0.92
POCF ratio	5.45	6.22	5.57	6.09	5.75
PFCF ratio	10.21	80.71	8.31	12.27	30.95
P/B Ratio	1.22	0.92	1.13	0.78	0.75
PTB ratio	1.22	0.92	1.13	0.78	0.75
EV to sales	1	0.87	1.04	0.6	0.6
Enterprise value over EBITDA	5.65	5.25	4.81	2.65	2.93
EV to operating cash flow	5.22	5.84	4.63	4.15	3.76
EV to free cash flow	9.79	75.85	6.92	8.37	20.27
Earnings yield	0.06	0.06	0.07	0.16	0.07
Free cash flow yield	0.1	0.01	0.12	0.08	0.03
Debt to equity	0.38	0.34	0.24	0.13	0.09
Debt to assets	0.22	0.22	0.16	0.1	0.07
Net debt to EBITDA	-0.24	-0.34	-0.97	-1.24	-1.55
Current ratio	2.44	3	3.12	3.12	3.22
Interest coverage	88.08	61.72	107.39	130.94	109.81
Income quality	2	2.25	1.85	0.79	1.67
Dividend Yield	0.01	0.02	0.01	0.02	0.03
Payout ratio	0.23	0.32	0.2	0.12	0.36
Sales general and administrative to revenue	0.11	0.13	0.13	0	0.07
Research and developement to revenue	0.04	0.04	0.02	0.02	0.02
Intangibles to total assets	0.01	0.01	0.01	0.01	0
Capex to operating cash flow	-0.47	-0.92	-0.33	-0.5	-0.81
Capex to revenue	-0.09	-0.14	-0.07	-0.07	-0.13
Capex to depreciation	-1.05	-1.44	-0.8	-1	-1.77
Stock based compensation to revenue	0	0	0	0	0
Graham number	3.23K	2.97K	3.83K	5.63K	3.83K
ROIC	0.05	0.04	0.06	0.07	0.04
Return on tangible assets	0.04	0.04	0.06	0.1	0.04
Graham Net	161.04	274.61	603.9	842.8	848.12
Working capital	18.22B	18.83B	20.04B	20.78B	19.72B
Tangible asset value	33.35B	34.07B	36.24B	42.35B	42.9B
Net current asset value	9.32B	9.77B	13.34B	16.71B	16.3B
Invested capital	0.38	0.34	0.24	0.13	0.09
Average receivables	9.82B	8.89B	8.29B	8.55B	7.86B
Average payables	2.78B	2.57B	1.75B	1.55B	1.61B
Average inventory	6.28B	5.84B	5.18B	5.07B	5.38B
Days sales outstanding	91.84	87.87	93.93	84.41	73.2
Days payables outstanding	36.1	28.72	20.16	22.41	19.17
Days of inventory on hand	74.1	74.15	72.04	67.73	71.72
Receivables turnover	3.97	4.15	3.89	4.32	4.99
Payables turnover	10.11	12.71	18.11	16.29	19.04
Inventory turnover	4.93	4.92	5.07	5.39	5.09
ROE	0.07	0.06	0.08	0.13	0.05
Capex per share	-265.24	-359.95	-189.44	-214.46	-374.23

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	716.33	591.95	607.46	598.52	732.79
Net income per share	-112.93	51.77	57.77	33.34	50.88
Operating cash flow per share	103.16	111.7	113.53	115.23	120.55
Free cash flow per share	103.16	111.7	113.53	115.23	120.55
Cash per share	1.22K	1.29K	1.4K	1.43K	1.39K
Book value per share	3.53K	3.57K	3.62K	3.68K	3.71K
Tangible book value per share	3.53K	3.57K	3.62K	3.68K	3.71K
Share holders equity per share	3.53K	3.57K	3.62K	3.68K	3.71K
Interest debt per share	358	327.36	408.77	458.51	434.32
Market cap	29.88B	31.73B	37.54B	37.35B	38.85B
Enterprise value	19.44B	20.56B	25.63B	26.02B	27.34B
P/E ratio	-5.48	12.75	13.52	23.28	15.87
Price to sales ratio	3.45	4.46	5.14	5.19	4.41
POCF ratio	23.98	23.64	27.52	26.95	26.79
PFCF ratio	23.98	23.64	27.52	26.95	26.79
P/B Ratio	0.7	0.74	0.86	0.84	0.87
PTB ratio	0.7	0.74	0.86	0.84	0.87
EV to sales	2.25	2.89	3.51	3.61	3.1
Enterprise value over EBITDA	20.15	32.78	32.66	35.65	14.49
EV to operating cash flow	15.6	15.32	18.79	18.78	18.85
EV to free cash flow	15.6	15.32	18.79	18.78	18.85
Earnings yield	-0.05	0.02	0.02	0.01	0.02
Free cash flow yield	0.04	0.04	0.04	0.04	0.04
Debt to equity	0.1	0.09	0.11	0.12	0.12
Debt to assets	0.08	0.07	0.09	0.09	0.09
Net debt to EBITDA	-10.82	-17.82	-15.17	-15.51	-6.1
Current ratio	3.46	3.22	3.59	3.59	3.97
Interest coverage	82.3	40.55	116.4	90	193.67
Income quality	-0.91	2.16	1.97	3.46	2.37
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.02	0.04	0.02	0.02	0.02
Intangibles to total assets	0.01	0	0	0	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	3K	2.04K	2.17K	1.66K	2.06K
ROIC	0.02	0.01	0.01	0.01	0.02
Return on tangible assets	-0.02	0.01	0.01	0.01	0.01
Graham Net	972.53	932.61	974.11	960.65	961.98
Working capital	20.57B	19.72B	21.42B	21.63B	22.25B
Tangible asset value	42.63B	42.9B	43.48B	44.27B	44.64B
Net current asset value	16.95B	16.3B	16.85B	16.45B	16.91B
Invested capital	0.1	0.09	0.11	0.12	0.12
Average receivables	8.65B	7.79B	6.83B	6.49B	6.49B
Average payables	2.01B	1.62B	1.41B	1.21B	1.4B
Average inventory	5.06B	5.36B	5.53B	5.88B	5.83B
Days sales outstanding	88.46	89.46	81.29	79.9	67.2
Days payables outstanding	23.45	23.11	21.24	16.61	23.22
Days of inventory on hand	69.01	86.48	87.04	97.35	73.12
Receivables turnover	1.02	1.01	1.11	1.13	1.34
Payables turnover	3.84	3.89	4.24	5.42	3.88
Inventory turnover	1.3	1.04	1.03	0.92	1.23
ROE	-0.03	0.01	0.02	0.01	0.01
Capex per share	0	0	0	0	0

4109.T Dividend History

4109.T Frequently Asked Questions

What is Stella Chemifa Corporation stock symbol ?

Stella Chemifa Corporation is a JP stock and trading under the symbol 4109.T

What is Stella Chemifa Corporation stock quote today ?

Stella Chemifa Corporation stock price is $3710 today.

Is Stella Chemifa Corporation stock public?

Yes, Stella Chemifa Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 33K
Market Capitalization 44.92B
Employee 727
CEO Ms. Aki Hashimoto
Headquarters Osaka,JP
IPO Date 2001-01-04
Website https://www.stella-chemifa.co.jp

Stella Chemifa Corporation manufactures and sells inorganic fluorine compounds in Japan and internationally. It offers hydrofluoric acid, buffered hydrofluoric acid, and etching solutions used in semiconductors, liquid crystal products, and solar batteries; calcium, aluminum, lithium, strontium, barium, magnesium, zinc, and lead fluoride used in optical materials; and lithium hexafluorophosphate for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and anhydrous hydrofluoric acid and 55% hydrofluoric acid used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as fluorosilicic acid, potassium fluorosilicate, ammonium fluorosilicate, fluoroboric acid, tin fluoroborate, copper fluoroborate, lead fluoroborate, zinc fluoroborate, sodium fluoroborate, potassium fluoroborate, ammonium hydrogenfluoride, sodium fluoride, potassium fluoride, ammonium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, refined calcium fluoride, and potassium hexafluorophosphate. Further, the company transports a range of special chemical substances, high-pressure gas, hazardous materials, and related products. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.